Aadi Bioscience Provides PRECISION1 Trial and Corporate Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. META
6. BA
7. SPY
8. INTC
9. JBLU
10. HOOD

Go back to Aadi Bioscience Provides PRECISION1 Trial and Corporate Updates

Jefferies Downgrades Aadi Bioscience Inc (AADI) to Hold

August 21, 2024 3:47 PM EDT

Jefferies analyst Roger Song downgraded Aadi Bioscience Inc (NASDAQ: AADI) from Buy to Hold with a price target of $1.50 (from $11.00).

The analyst comments "We spoke w/ mgmt following IDMC demonstrated nab-sirolimus (mTOR) tumor agonostic pivotal in TSC1/TSC2 tumors was unlikely to... More

TD Cowen Downgrades Aadi Bioscience Inc (AADI) to Hold

August 21, 2024 4:47 AM EDT

TD Cowen analyst Boris Peaker downgraded Aadi Bioscience Inc (NASDAQ: AADI) from Buy to Hold.

The analyst comments "Aadi management announced that the PRECISION1 trial in TSC1/2 solid tumors will be discontinued due to low probability of meeting the efficacy threshold needed for accelerated... More